London & Capital Asset Management’s Quest Diagnostics DGX Stock Holding History

London & Capital Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-66,731	Closed	-$7.64M	–	76
2020 Q3	$7.64M	Buy	+66,731	New	+$7.88M	1.02%	31
2020 Q1	–	Sell	-67,906	Closed	-$7.25M	–	84
2019 Q4	$7.25M	Sell	67,906 -3,274	-5%	-$341K	1.17%	22
2019 Q3	$7.62M	Buy	71,180 +63,139	+785%	+$6.48M	1.3%	22
2019 Q2	$819K	Sell	8,041 -78,710	-91%	-$7.56M	0.17%	52
2019 Q1	$7.8M	Sell	86,751 -202,270	-70%	-$17.5M	1.17%	21
2018 Q4	$24.1M	Buy	+289,021	New	+$27.1M	3.69%	11

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

London & Capital Asset Management's DGX Position: Q4 2020 in Review

London & Capital Asset Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 66,731 shares — an estimated $7.64M sold.

London & Capital Asset Management first reported a position in DGX in Q4 2018 and held it in 6 quarters. The position peaked at $24.1M in Q4 2018. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

London & Capital Asset Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
London & Capital Asset Management sold 66,731 Quest Diagnostics shares in Q4 2020, an estimated $7.64M.
London & Capital Asset Management first reported a position in Quest Diagnostics in Q4 2018 and held it in 6 quarters.
London & Capital Asset Management's Quest Diagnostics position peaked at $24.1M in Q4 2018.
812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on London & Capital Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.